Newsletter Signup x
Rhabdomyosarcoma (RMS) is a childhood cancer that develops in muscle, with 50 new cases every year in the UK. Older children in particular have a poor outlook and we need to improve our understanding of the disease in order to develop new approaches to treatment. Professor Birch is carrying out a detailed investigation of the genetic mutations underlying RMS development, which we hope, ultimately, will direct new, personalised treatment strategies.
This research project on rhabdomyosarcoma has been successfully completed. Your donations allow us to fund ground-breaking research that can improve treatments given to children with cancer. Thank you. Your help allows us to continue to find ways to drive up the chances of survival for children with cancer and reduce the toxic side effects that can affect the rest of their lives.
Identification of new genetic changes in rhabdomyosarcoma
Professor Jill Birch
University of Manchester
Manchester M13 9PL
1 June 2013
40 months
£96,816
Patient Story – Matilda T
Matilda was diagnosed with B-cell acute lymphoblastic leukaemia on 24 February 2022 when she was just three years old.
Read morePatient Story – Lucie
Lucie was diagnosed with a brain tumour when she was only five weeks old. Her mum Philippa tells their
Read more